Bank of America’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $263M | Buy |
|
|||||
|
2021
Q1 | $144M | Sell |
|
|||||
|
2020
Q4 | $283M | Sell |
|
|||||
|
2020
Q3 | $227M | Buy |
|
|||||
|
2020
Q2 | $217M | Buy |
|
|||||
|
2020
Q1 | $161M | Buy |
|
|||||
|
2019
Q4 | $185M | Sell |
|
|||||
|
2019
Q3 | $198M | Sell |
|
|||||
|
2019
Q2 | $272M | Buy |
|
|||||
|
2019
Q1 | $280M | Buy |
|
|||||
|
2018
Q4 | $177M | Sell |
|
|||||
|
2018
Q3 | $311M | Buy |
|
|||||
|
2018
Q2 | $243M | Sell |
|
|||||
|
2018
Q1 | $248M | Buy |
|
|||||
|
2017
Q4 | $194M | Sell |
|
|||||
|
2017
Q3 | $299M | Buy |
|
|||||
|
2017
Q2 | $212M | Buy |
|
|||||
|
2017
Q1 | $199M | Sell |
|
|||||
|
2016
Q4 | $211M | Sell |
|
|||||
|
2016
Q3 | $227M | Sell |
|
|||||
|
2016
Q2 | $239M | Sell |
|
|||||
|
2016
Q1 | $356M | Sell |
|
|||||
|
2015
Q4 | $507M | Buy |
|
|||||
|
2015
Q3 | $362M | Buy |
|
|||||
|
2015
Q2 | $199M | Buy |
|
|||||
|
2015
Q1 | $173M | Sell |
|
|||||
|
2014
Q4 | $191M | Sell |
|
|||||
|
2014
Q3 | $182M | Sell |
|
|||||
|
2014
Q2 | $173M | Sell |
|
|||||
|
2014
Q1 | $180M | Buy |
|
|||||
|
2013
Q4 | $152M | Sell |
|
|||||
|
2013
Q3 | $143M | Buy |
|
|||||
|
2013
Q2 | $111M | Buy |
|